IDEAYA Biosciences
Gary Palmer, MD MBA, currently serves as the Senior Vice President of Medical Affairs at IDEAYA Biosciences since June 2025, following a tenure in the same role at Pliant Therapeutics. Prior leadership positions include Senior Vice President for Global Immunology & Neuroscience Medical Affairs at Bristol Myers Squibb and Senior Vice President for Global & US Medical Affairs at Myovant Sciences. Gary has extensive experience in medical affairs and leadership roles across pharmaceutical companies such as Actelion and Pfizer. An alumnus of the University of the Witwatersrand with an MD and MBA, Gary has furthered executive education through programs at MIT Sloan School of Management, Harvard Business School, and IMD.
This person is not in any teams
This person is not in any offices
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California